Загрузка...
Design of CD40 Agonists and their use in growing B cells for cancer immunotherapy
CD40 stimulation has produced impressive results in early-stage clinical trials of patients with cancer. Further progress will be facilitated by a better understanding of how the CD40 receptor becomes activated and the subsequent functions of CD40-stimulated immune cells. This review focuses on two...
Сохранить в:
| Главные авторы: | , , |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
2012
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3815466/ https://ncbi.nlm.nih.gov/pubmed/22804572 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3109/08830185.2012.703272 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|